‘Hinge-like’ protein hot-spot discovered: opening new doors for cystic fibrosis therapy
Potentiators targeting the cystic fibrosis transmembrane conductance regulator (CFTR) offer an effective treatment for cystic fibrosis. Scientists from the Rockefeller University (NY, USA) have identified CFTR’s key hot-spot, enabling the development of new and improved potentiators.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>